MJA Impact Factor tops 7 for first time: 17th in the world

Cate Swannell
Med J Aust
Published online: 1 July 2021

IN its fifth successive rise, the Medical Journal of Australia has reached its highest ever Journal Impact Factor (JIF) of 7.738, according to the 2020 Clarivate Analytics Journal Citation Report.

The MJA’s JIF has climbed from 3.369 in 2015, 3.675 in 2016, 4.227 in 2017, 5.332 in 2018, and 6.112 in the 2019 report, placing it firmly in the top 20 titles in Clarivate’s General and Internal Medicine category, ranked 17th in the world.

Laureate Professor Nicholas Talley, AC, editor-in-chief of the MJA, said that the result was further reward for the recommitment of the Journal to publishing high quality content.

“It is a tribute to the quality of Australian research and Australian researchers as well as the team at the Journal that the Clarivate JIF for the MJA has jumped to its highest ever level, from 6.112 last year to 7.738 this year,” said Professor Talley.

“Authors want to have an impact on medical practice and policy, and the MJA is an excellent choice for medical researchers and practitioners. Thank you for supporting the MJA.”

The Clarivate Journal Impact Factor is based upon numbers of citations of journal articles by other peer-reviewed journals.

In other MJA news, Professor Talley has agreed to extend his contract as Editor-in-Chief for a further two years.

  • Cate Swannell



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.